HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc Ostermeier Selected Research

nucleoside phosphotransferase

2/2017Development of a cancer-marker activated enzymatic switch from the herpes simplex virus thymidine kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc Ostermeier Research Topics

Disease

7Neoplasms (Cancer)
10/2020 - 02/2009
3Hypoxia (Hypoxemia)
01/2019 - 09/2011
1Fibrosarcoma
01/2019
1Tuberculosis (Tuberculoses)
12/2014
1Human Influenza (Influenza)
08/2013

Drug/Important Bio-Agent (IBA)

7ProdrugsIBA
10/2020 - 02/2009
5EnzymesIBA
01/2019 - 09/2011
4Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2011
2Flucytosine (Ancobon)FDA Link
10/2020 - 01/2019
1Fluorouracil (Carac)FDA LinkGeneric
01/2019
1Cytosine DeaminaseIBA
01/2019
1Oxygen (Dioxygen)IBA
01/2019
1nucleoside phosphotransferaseIBA
02/2017
1Thymidine KinaseIBA
02/2017
1Tumor Biomarkers (Tumor Markers)IBA
02/2017
1Phosphotransferases (Kinase)IBA
12/2014
1Glucose (Dextrose)FDA LinkGeneric
03/2014
1Lactic Acid (Lactate)FDA LinkGeneric
03/2014
1MaltoseIBA
03/2014
1Codon (Codons)IBA
08/2013
1Hemagglutinins (Hemagglutinin)IBA
08/2013

Therapy/Procedure

6Therapeutics
01/2019 - 02/2009
1Molecular Targeted Therapy
03/2014